| # | Drug | Count |
|---|---|---|
| 0 | PAROXETINE HYDROCHLORIDE | 52 |
| 1 | PREDNISONE | 52 |
| 2 | CICLESONIDE | 50 |
| 3 | IPRATROPIUM BROMIDE | 50 |
| 4 | MONTELUKAST SODIUM | 50 |
| 5 | VALSARTAN | 50 |
| 6 | VALSARTAN ORAL | 50 |
| 7 | DULOXETINE | 46 |
| 8 | DULOXETINE HYDROCHLORIDE | 46 |
| 9 | ERGOCALCIFEROL | 46 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE | 1 | 0.0244 |
| 1 | BUPROPION HYDROBROMIDE | 13 | 0.0225 |
| 2 | GLYCOPYRROLATE | 26 | 0.0046 |
| 3 | THEOPHYLLINE ANHYDROUS | 46 | 0.0037 |
| 4 | CICLESONIDE | 50 | 0.0036 |
| 5 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 27 | 0.0018 |
| 6 | ERGOCALCIFEROL | 46 | 0.0015 |
| 7 | IPRATROPIUM BROMIDE | 50 | 0.0014 |
| 8 | PAROXETINE HYDROCHLORIDE | 52 | 0.0012 |
| 9 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 16 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 58 |
| 1 | Angiotensin 2 Receptor Blocker [EPC] | 51 |
| 2 | Methylxanthine [EPC] | 46 |
| 3 | Provitamin D2 Compound [EPC] | 46 |
| 4 | Estrogen [EPC] | 33 |
| 5 | Proton Pump Inhibitor [EPC] | 28 |
| 6 | Thiazide Diuretic [EPC] | 18 |
| 7 | Leukotriene Receptor Antagonist [EPC] | 15 |
| 8 | Kinase Inhibitor [EPC] | 6 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 46 | 0.0015 |
| 1 | Methylxanthine [EPC] | 46 | 0.0008 |
| 2 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 3 | Leukotriene Receptor Antagonist [EPC] | 15 | 0.0005 |
| 4 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 5 | Estrogen [EPC] | 33 | 0.0002 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 51 | 0.0002 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Cholinesterase Inhibitor [EPC] | 2 | 0.0001 |
| 9 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |